Burkitt Lymphoma International Prognostic Index

202180 citationsJournal Articlegreen Open Access

Authors

Adam J. Olszewski · Brown University

Lasse H. Jakobsen · Aalborg University Hospital

Graham P. Collins · Oxford University Hospitals NHS Trust

Kate Cwynarski · University College London Hospitals NHS Foundation Trust

Veronika Bachanova · University of Minnesota

Kristie A. Blum · Emory University

Kirsten M. Boughan · University Hospitals Seidman Cancer Center

Mark Bower

Abstract

The BL-IPI provides robust discrimination of survival in adult BL, suitable for use as prognostication and stratification in trials. The high-risk group has suboptimal outcomes with standard therapy and should be considered for innovative treatment approaches.

Topics & Keywords

Lymphoma Diagnosis and Treatment CNS Lymphoma Diagnosis and Treatment Viral-associated cancers and disorders

Publication Details

Published in: Journal of Clinical Oncology

Volume 39, Issue 10, pp. 1129-1138

DOI: 10.1200/jco.20.03288

Field-Weighted Citation Impact: 8.66

Command Palette

Burkitt Lymphoma International Prognostic Index

Authors

Abstract

Topics & Keywords

Publication Details